Lithuania vs New Zealand: Immunization, Hib3
Lithuania
89.0%
in 2024
New Zealand
89.0%
in 2024
Lithuania rank
108th
New Zealand rank
108th
Immunization, Hib3 over time
- Lithuania
- New Zealand
How they compare
Lithuania currently reports 89.0% against 89.0% in New Zealand, a difference of 0.0%.
The two have swapped places 12 times across 26 shared years of data; in 1999 it was New Zealand ahead.
Lithuania ranks 108th and New Zealand ranks 108th of 191 countries.
Across the 4 decades both report, Lithuania averaged higher in 2 and New Zealand in 2.
Head to head by decade
| Decade | Lithuania | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 2.0% | 88.0% | 86.0% | New Zealand |
| 2000s | 50.0% | 85.8% | 35.8% | New Zealand |
| 2010s | 93.1% | 92.1% | 1.0% | Lithuania |
| 2020s | 90.0% | 89.6% | 0.4% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Lithuania or New Zealand?
- Lithuania, at 89.0% against 89.0% in New Zealand as of 2024.
- What is the difference in immunization, hib3 between Lithuania and New Zealand?
- 0.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and New Zealand?
- 26 years are reported by both, from 1999 to 2024.
- How do Lithuania and New Zealand rank globally for immunization, hib3?
- Lithuania ranks 108th and New Zealand ranks 108th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.